Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats

https://doi.org/10.1016/S0166-4328(96)02262-0Get rights and content

Abstract

Some studies have indicated that aged rats have elevated basal levels of vacuous jaw movements and these vacuous jaw movements are exacerbated by classic neuroleptic drugs like haloperidol, but the effects of the atypical antipsychotic clozapine on vacuous jaw movements in aged rats has not previously been studied. Aged rats were administered daily intraperitoneal injections of either haloperidol (0.04, 0.1 or 0.4 mg/kg), clozapine (0.4, 1.0, 4.0 mg/kg) or 0.3% tartaric acid vehicle for 22 days. On days 1, 8, 15 and 22 these rats were placed in an observation tube and vacuous jaw movements were recorded by two trained observers. Vacuous jaw movements were present in the aged rats receiving vehicle. Haloperidol produced a dose-dependent increase in vacuous jaw movements while clozapine produced a dose-dependent attenuation of vacuous jaw movements, relative to the vehicle-treated rats. These results indicate that screening for vacuous jaw movements may provide a useful behavioral assay for atypical antipsychotic drugs which do not produce extrapyramidal side effects and that clozapine's resistance to these side effects may extend to populations of elderly human patients.

Introduction

Clozapine has been effective in treating schizophrenics and schizophrenics who have been resistant to classical neuroleptics, without a high incidence of extrapyramidal side effects 12, 18, 20, 27, 35, 63. The long-term effects of clozapine have been reported to be superior to those observed with typical neuroleptic drugs 36, 39, 50. Furthermore, clozapine does not appear to produce tardive dyskinesia 10, 37and appears to be an effective treatment for tardive dyskinesia that is unresponsive to other remedial forms of treatment 21, 38, 46. Clozapine is believed to have stronger effects on the mesocorticolimbic dopamine system, rather than the nigrostriatal system 2, 5, 6, 8, 33and this property is believed to he essential for blocking psychosis without producing extrapyramidal side effects [1].

Classic antipsychotic drugs produce a syndrome of vacuous jaw movements in rats, which is characterized by a rapid opening and closing of the jaw which is not directed at any particular stimulus 13, 23, 29, 30, 57, 58, 59, 67, 69. The effects of antipsychotic drugs in aged rats has important implications for human functioning, given that there is an increased incidence of extrapyramidal side effects with classic neuroleptic administration to elderly humans 3, 15, 34and these symptoms sometimes remain after discontinuation of drug [66]. These increases may reflect changes in catecholamine functioning that are age-related in humans [51], such as cell loss of neurons in the putamen [7]. Similar changes in dopaminergia functioning have been found in rats 16, 25, 33, 64, 71. For example, age-related impairments in catecholamine functioning have been established at the pre- and post-synaptic levels in the basal ganglia and hypothalamus of rats and primates 17, 43. Several studies have indicated that spontaneous non-drug induced vacuous jaw movements in rats increase with age 26, 31, 60, 69, 73, 74, and these vacuous jaw movements have been linked to striatal dopamine functioning [30].

Clozapine has reportedly been given to individuals of all ages 45, 50, but there is only a single case study in the literature supporting the use of clozapine in the treatment of the elderly [4]. Acute administration of clozapine does not elevate vacuous jaw movements in young rats 26, 31or produce dystonias in adult monkeys [11]. The administration of clozapine for 12 months to young adult rats does produce elevations in vacuous jaw movements [58]. However, the effects of acute administration of clozapine to aged rats has not yet been explored. The purpose of the present set of experiments is to determine the impact of clozapine and haloperidol on vacuous jaw movements in a group of aged rats. The doses selected for repeated administration in the present study were selected because of their ability to partially reverse psychotomimetic-induced social withdrawal [68]and from parallel findings with these doses in young rats [67].

Section snippets

Subjects

The subjects in this experiment were 36 male Sprague-Dawley rats obtained from Harlan Sprague–Dawley (Indianapolis, IN). The rats were between 20 and 24 months of age at the start of the study and weighed between 500 and 650 g. All rats were housed individually in a colony room maintained at 20°C, with a 12-h light/dark cycle (lights on at 07:00 h). Standard lab chow and water were available ad libitum.

Drugs

Haloperidol was obtained from Sigma (St. Louis, MO) and injected in doses of either 0.04,

Results

Interrater reliabilities for the two observers were calculated using the Pearson r on each day of the study. The two observers achieved an interrater reliability of 0.88 or better on all 4 observation days. Therefore, all data analysis was performed on the arithmetic mean of the observer's vacuous jaw movement tallies.

The effect of each drug on vacuous jaw movements was analyzed separately using a mixed three by four ANOVA, with repeated measures across days. The results of the effect of

Discussion

The results of the present study indicated that 0.4 mg/kg of haloperidol elevated vacuous jaw movements in aged rats after the first administration and these elevations became more pronounced with repeated administration. The 0.1 mg/kg of haloperidol elevated vacuous jaw movements in this population with repeated administration. The findings regarding haloperidol are consistent with the literature on perioral movements in rats [69]and monkeys [22]. While clozapine does not elevate vacuous jaw

References (75)

  • Altar, C.A., Wasley, A.M., Neale, R.F. and Stone, G.E., Typical and atypical antipsychotic occupancy of D2 and S2...
  • Anden, N.E. and Stock, G., Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic...
  • Ayd, F.J., A survey of drug-induced extrapyramidal reactions, J. Am. Med. Assoc., 175 (1975)...
  • Ball, C.J., The use of clozapine in older people, Int. J. Geriat. Psychiatry, 7 (1992)...
  • Bartholini, G., Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system,...
  • Bartholini, G., Preferential effect of noncataleptogenic neuroleptics on the mesocortical dopaminergic function, Adv....
  • Bugiani, O., Salvarini, S., Perdelli, F., Mancardi, G.L. and Leonardi, A., Nerve cell loss with aging in the putamen,...
  • Burki, H.R., Eichenberger, E., Sayers, A.C. and White, T.G., Clozapine and the dopamine hypothesis of schizophrenia, a...
  • Carlsson, A. and Winblad, B., The influence of age and time interval between death and autopsy on dopamine and...
  • Casey, D.E., Clozapine: Neuroleptic-induced EPS and tardive dyskinesia, Psychopharmacology, 99 (1989)...
  • Casey, D.E., Antipsychotic drugs in schizophrenia: newer compounds and differential outcomes, Psychopharmacol. Bull.,...
  • Chouinard, G. and Annable, L., Clozapine in the treatment of newly admitted schizophrenic patients: a pilot study, J....
  • Clow, A.T., Jenner, P. and Marsden, C.D., An experimental model of tardive dyskinesia, Life Sci., 23 (1979)...
  • Coward, D.M., Imperato, A., Urwyler, S. and White, T.G., Biochemical and behavioral properties of clozapine,...
  • Crane, G.E., Factors predisposing to drug-induced neurologic effects. In F.S. Forrest, C.J. Carr and E. Usdin (Eds.),...
  • Finch, C.E., Catecholamine metabolism in the brains of ageing male mice, Brain Res., S2 (1973)...
  • Finch, C.E., Neuroendocrine and autonomic aspects of aging. In C.E. Finch and L. Hayflick (Eds.), Handbook of the...
  • Fischer-Cornelssen, K.A. and Ferner, U.J., An example of European multicenter trials: multispectral analysis of...
  • Garver, D.L., Davis, J.M., Dekirmenjian, H., Ericksen, S., Gosenfeld, L. and Haraszti, J., Dystonic reactions following...
  • Gellenberg, A.J. and Doller, J.C., Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary...
  • Gerbino, L., Shopsin, B. and Collora, M., Clozapine in the treatment of tardive dyskinesia: an interim report. In W.E....
  • Gerlach, J. and Casey, D.E., Remoxipride, a new selective D2 antagonist, and haloperidol in Cebus monkeys, Prog....
  • Glassman, R.B. and Glassman, H.N., Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for...
  • Govoni, S., Loddo, P., Spano, P.F. and Trabucci, M., Dopamine receptor sensitivity in brain and retina of rats during...
  • Govoni, S., Spano, P.F. and Trabucchi, M., [3H]Haloperidol and [3H]spiroperidol binding in the rat striatum during...
  • Gunne, L.M., Andersson, U., Bondesson, U. and Johansson, P., Spontaneous chewing movements in rats during acute and...
  • Honigfeld, G., Patin, J. and Singer, J., Clozapine: Antipsychotic activity in treatment-resistant schizophrenics, Adv....
  • Hyttel, J., Larsen, J.J., Christensen, A.V. and Arnt, J., Receptor-binding profiles of neuroleptics. In: D.E. Casey,...
  • Iversen, S.D., Howells, R.B. and Hughs, R.P., Behavioral consequences of long-term treatment with neuroleptic drugs,...
  • Jicha, G. and Salamone, J.D., Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine...
  • Johansson, P., Casey, D.E. and Gunne, L.M., Dose-dependent increases in rat spontaneous chewing rats during longterm...
  • Jonec, V.J. and Finch, C.E., Senescence and dopamine uptake by subcellular fractions of the C57BL/6J male mouse brain,...
  • (a) Joseph, J.A., Berger, R.E., Engel, B.T. and Roth, G.S., Age-related changes in the nigrostriatum: a behavioral and...
  • Jus, A., Pineau, R., Lachance, R., Pelchat, G., Jus, K., Pires, P. and Villeneuve, R., Epidemiology of tardive...
  • Kane, J., Honigfield, G., Singer, J., Meltzer, H.Y., et al., Clozapine for the treatment resistant schizophrenic: a...
  • Kuha, S. and Miettinco, E., Long-term effect of clozapine in schizophrenia: a retrospective investigation of 216...
  • Liebermann, J., Kane, J., Johns, C. and Vital-Herne, J., Clozapine: clinical evidence of novel effects, Clin....
  • Cited by (0)

    View full text